You have read all your free articles, to continue reading subscribe to read the rest of this content.
Genetic Analysis has been awarded an important patent by the China National Intellectual Property Agency (CNIPA). The patent entitled “A method for determining gastrointestinal tract dysbiosis” covers the company’s algorithm incorporated in the GA-map technology for profiling gut microbiotaAlready a subscriber Login You have read all your free articles, to…
The U.S. Food and Drug Administration (FDA) has informed Veloxis Pharmaceuticals A/S that the FDA still maintains that the exclusivity for Astagraf XL should require delays in the formal approval of Envarsus® XR. The FDA has stated that it would be prepared to approve Envarsus XR for use onlAlready a…
The United States Patent and Trademark Office (USPTO) has granted the company's patent application directed to gluconic acid derivatives for preventing and/or treating bacterial infections. “The US patent covering treatment and prevention of vaginal bacterial infections by GDL, or pHyph, strengAlready a subscriber Login You have read all your free…
Targovax announces the grant of European Patent no 2,379,586. This composition of matter patent protects Targovax's lead product from its ONCOS platform, the oncolytic viral product ONCOS-102 and expires in 2029. A US patent covering ONCOS-102 was granted in May 2016. Targovax's proprietary ONAlready a subscriber Login You have read…
